Regulatory adaptive status in determining the effectiveness of treatment with bisoprololum and nebivololum in patients with paroxysmal atrial fibrillation and hypertension
Increase in mortality from cardiovascular causes, systemic thromboembolism, congestive heart failure, increased frequency of hospitalization and deterioration in quality of life is associated with atrial fibrillation (AF). Essential hypertension (EH) is the most common cause of AF. To prevent recurr...
Main Authors: | M. A Eremina, V. G Tregubov, V. M Pokrovskiy |
---|---|
Format: | Article |
Language: | English |
Published: |
Concilium Medicum
2018-03-01
|
Series: | КардиоСоматика |
Subjects: | |
Online Access: | https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45931/pdf |
Similar Items
-
Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal atrial fibrillation
by: M A Eremina, et al.
Published: (2016-12-01) -
Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal supraventricular tachycardia
by: N M Nazhalkina, et al.
Published: (2017-12-01) -
Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal supraventricular tachycardia
by: Nazhalkina N.M., et al.
Published: (2017-11-01) -
Regulatory adaptive status in determining the effectivenessof bisoprololum and sotalolum in patients with hypertensive disease and ventricular arrhythmias
by: I Z Shubitidze, et al.
Published: (2016-03-01) -
COMPARISON OF TREATMENT EFFICACY IN PAROXYSMAL ATRIAL FIBRILLATION
by: V. G. Tregubov, et al.
Published: (2017-04-01)